The BioInnovation Institute (BII), is an international non-profit foundation in Denmark that incubates and accelerates world-class life science research. They have just announced that twelve companies have been selected to join their 12 month Venture Lab acceleration program which supports startup companies with business acceleration, scientific, and team development. The program also provides each startup with a €500 thousand ($541K USD) convertible loan and access to BII’s labs and offices in Copenhagen. Of the twelve companies, three of them work in quantum technology including Alea Quantum Technologies, a company developing quantum random number generators, DiaSense, a company working on diamond-magnetic microscopes for use neuroscientists to diagnose diseases and find cures, and Sqale ApS, a company leveraging quantum-enhanced optimization, agile pipeline development, and other techniques to revolutionize biopharmaceutical manufacturing. More details about this program and companies selected can be seen in a news release posted on the BII website here.

March 1, 2024